Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agents

Bibliography

• KAWAUCHI H, KAWAZOE I, TSUBOKAWA M, KISHIDA M, BAKER BI: Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature (1983) 305:321–323.
   PubMed Web of Science ®Google Scholar
• SKOFITSCH G, JACOBOWITZ DM, ZAMIR N: Immunohistochemical localization of a melanin-concentrating hormone-like peptide in the rat brain. Brain Res. Bull. (1985) 15:635–649.
   PubMed Web of Science ®Google Scholar
• VAUGHAN JM, FISCHER WH, HOEGER C, RIVIER J, VALE W: Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology (1989) 125:1660–1665.
   PubMed Web of Science ®Google Scholar
• PRESSE F, NAHON JL, FISCHER WH, VALE W: Structure of the human melanin concentrating hormone mRNA. Mol Endocrinol (1990) 4:632–637.
   PubMedGoogle Scholar
• GONZALEZ MI, BAKER BI, HOLE DR, WILSON CA: Behavioral effects of neuropeptide E-I (NEI) in the female rat: interactions with a-MSH, MCH and dopamine. Peptides (1998) 19:1007–1016.
   PubMed Web of Science ®Google Scholar
• SANCHEZ M, BAKER BI, CELIS M: Melanin-concentrating hormone (MCH) antagonizes the effects of a-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides (1997) 18:393–396.
   PubMed Web of Science ®Google Scholar
• CHAMBERS J, AMES RS, BERGSMA D et al.: Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 400:261–265.
   PubMed Web of Science ®Google Scholar
• ••Identification of the first receptor forMCH.
   Google Scholar
• SHIMOMURA Y, MORI M, SUGO T et al.: Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem. Biophys. Res. Comm. (1999) 261:622.
   PubMed Web of Science ®Google Scholar
• BACHNER D, KREIENKAMP H-J, WEISE C, BUCK F, RICHTER D: Identification of melanin-concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett. (1999) 457:522–524.
   PubMed Web of Science ®Google Scholar
• SAITO Y, NOTHACKER H-P, WANG Z et al.: Molecular characterization of the melanin-concentrating-hormone receptor. Nature (1999) 400:265–269.
   PubMed Web of Science ®Google Scholar
• KOLAKOWSKI LF Jr, JUNG BP, NGUYEN T et al.: Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. (1996) 398:253–258.
   PubMed Web of Science ®Google Scholar
• HERVIEU G, CLUDERAY J, HARRISON D et al.: The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, s/c-/, in the central nervous system of the rat. Eu. NeuroscL (2000) 12:1194–1216.
   PubMed Web of Science ®Google Scholar
• WANG S, BEHAN J, O'NEILL K et al.: Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2. Biol. Chem. (2001) 276:34664–34670.
   Google Scholar
• •Identification of the second MCH receptor.
   Google Scholar
• HILL J, DUCKWORTH M, MURDOCK P et al: Molecular cloning and functional characterization of MCH2, a novel human MCH receptor.' Biol. Chem. (2001) 276:20125–20129.
   Google Scholar
• MORI M, HARADA M, TERAO Yet al.: Cloning of a novel G-protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem. Biophys. Res. Commun. (2001) 283:1013–1018.
   Google Scholar
• SAILER AW, SANO H, ZENG Z et al.: Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. PNAS (2001) 98:7564–7569.
   PubMed Web of Science ®Google Scholar
• AN S, CUTLER G, ZHAO JJ et al: Identification and characterization of a melanin-concentrating hormone receptor. PNAS (2001) 98:7576–7581.
   PubMed Web of Science ®Google Scholar
• TAN CP, SANO H, IWAASA H et al.: Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Cenomics (2002) 79:785–792.
   Google Scholar
• •Expression of the two receptor subtypes in a variety of different species.
   Google Scholar
• BOUTIN JA, SUPLY T, AUDINOT V et al.: Melanin-concentrating hormone and its receptors: state of the art. Can. Physiol Pharmacol (2002) 80:388–385.
   PubMed Web of Science ®Google Scholar
• •A review of the pharmacology of MCH and its receptors.
   Google Scholar
• MACDONALD D, MURGOLO N, ZHANG R et al: Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation. Ma Pharmacol (2000) 58:217–225.
   PubMed Web of Science ®Google Scholar
• BEFORT K, ZILLIOX C, FILLIOL D, YUE S, KIEFFER BL: Constitutive activation of the 8-opioid receptor by mutations in transmembrane domains III and VII. J Biol. Chem. (1999) 274:18574–18581.
   PubMed Web of Science ®Google Scholar
• SURRATT CK, JOHNSON PS, MORIWAKI A et al.: p-Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. Biol. Chem. (1994) 269:20548–20553.
   Google Scholar
• NEHRING RB, MEYERHOF W, RICHTER D: Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol. (1995) 14:939–944.
   PubMed Web of Science ®Google Scholar
• BEDNAREK MA, FEIGHNER SD, HRENIUK DL et al.: Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2. Biochemistry(2001) 40:9379–9386.
   PubMed Web of Science ®Google Scholar
• AUDINOT V, BEAU VERGER P, LAHAYE C et al.: Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide figands at SLC-1, the human MCH receptor. I Biol. Chem. (2001) 276:13554–13562.
   Web of Science ®Google Scholar
• AUDINOT V, LAHAYE C, SUPLY T et al.: 125I-S36057: A new and highly potent radiofigand for the melanin-concentrating hormone receptor. Br: J. Pharmacol (2001) 133:371–378.
   Google Scholar
• SUPLY T, DELLA ZUANA 0, AUDINOT V et al.: SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity study. Pharmacol Exp. Ther. (2001) 299:137–146.
   Google Scholar
• QU D, LUDWIG DS, GAMMELTOFT S et al.: A role for melanin-concentrating hormone in the central regulation of feeding behavior. Nature (1996) 380:243–247.
   PubMed Web of Science ®Google Scholar
• ••First evidence that MCH is involved in thecontrol of food intake.
   Google Scholar
• TORRI C, PEDRAZZI P, LEO G et al.: Diet -induced changes in hypothalamic pro-opio-melanocortin mRNA in the rat hypothalamus. Peptides (2002) 23:1063–1068.
   PubMed Web of Science ®Google Scholar
• GAO J, GHIBAUDI L, VAN HEEK M, HWA JJ: Characterization of diet-induced obese rats that develop persistent obesity after 6 months of high-fat followed by 1 month of low-fat diet. Brain Res. Bull. (2002) 936:87–90.
   Google Scholar
• ROSSI M, CHOI SJ, O'SHEA D et al: Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 138:351–355.
   PubMed Web of Science ®Google Scholar
• ••Demonstration that intracerebroventricular administration of MCH results in marked hyperphagia in rodents
   Google Scholar
• GOMORI A, ISHIHARA A, ITO M et al.: Chronic intracerebroventricular infusion of MCH causes obesity in mice. Am. J. Physic] (2003) 284:E583–E588.
   Google Scholar
• ITO M, GOMORI A, ISHIHARA A et al.: Characterization of MCH-mediated obesity in mice. Am. J. Physic] (2003) 284:E940–E945.
   Google Scholar
• PRESSE F, NAHON JL: Differential regulation of melanin-concentrating hormone gene expression in distinct hypothalamic areas under osmotic stimulation in rat. Neuroscience (1993) 55:709–720.
   PubMed Web of Science ®Google Scholar
• SHEARMAN LP, CAMACHO RE, SLOAN STRIBLING D et al.: Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eu. Pharmacol (2003) 475:37–47.
   Google Scholar
• •Paper describing the effect of peptide agonists and antagonists on food intake and body weight.
   Google Scholar
• SHIMADA M, TRITOS NA, LOWELL BB, FLIER JS, MARATOS-FLIER E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 396:670–674.
   PubMed Web of Science ®Google Scholar
• ••Generation and phenotyping of MCHknockout mice.
   Google Scholar
• SEGAL-LIEBERMAN G, BRADLEY RL,KOKKOTOU E et aL: Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. PNAS (2003) 100:10085–10090.
   PubMed Web of Science ®Google Scholar
• LUDWIG DS, TRITOS NA, MASTAITIS JW et al.: Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. I Clin. Invest. (2001) 107:379–386.
   PubMed Web of Science ®Google Scholar
• CHEN Y, HU C, HSU C-K et al.: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology (2002) 143:2469–2477.
   PubMed Web of Science ®Google Scholar
• •Study of the MCH1R knockout mouse.
   Google Scholar
• MARSH DJ, WEINGARTH DT, NOVI DE et al.: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. PNAS (2002) 99:3240–3245.
   PubMed Web of Science ®Google Scholar
• •Study of the MCH1R knockout mouse.
   Google Scholar
• TAKEKAWA S, ASAMI A, ISHIHARA Y et al.: T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eu. Pharmacol (2002) 438:1239–1135.
   Web of Science ®Google Scholar
• ••First demonstration of the efficacy of aMCH antagonist in blocking MCH-induced hyperphagia.
   Google Scholar
• BOROWSKY B, DURKIN MM, OGOZALEK K et al.: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. (2002) 8:825–830.
   PubMed Web of Science ®Google Scholar
• ••Paper describing the effect of treatment ofdiet-induced obese rats with a potent and selective MCH antagonist.
   Google Scholar
• CARPENTER AJ, HERTZOG DL: Melanin-concentrating hormone receptor antagonists as potential antiobesity agents. Expert Opin. Ther. Patents (2002) 12:1639–1646.
   Web of Science ®Google Scholar
• MOKDAD AH, BOWMAN BA, FORD ES et al: The continuing epidemics of obesity and diabetes in the United States. J. Ain. Med. Assoc. (2001) 286:1195–2000.
   PubMed Web of Science ®Google Scholar
• WILLETT WC, DIETZ WH, COLDITZ GA: Guidelines for healthy weight. N Engl. J. Med. (1999) 341:427–434.
   PubMed Web of Science ®Google Scholar
• FORD ES, WILLIAMSON DF, LIU S: Weight change and diabetes incidence: findings from a national cohort of US adults. Am. j Epidemiol (1997) 146:214–212.
   PubMed Web of Science ®Google Scholar
• HELMRICH SP, RAGLAND DR, LEUNG RW, PAFFENBARGER RS: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. I Med. (1991) 325:147–152.
   PubMed Web of Science ®Google Scholar
• MCCARRON DA, REUSSER ME: Reducing cardiovascular disease risk with diet. Obesity Res. (2001) 9:335S–340S.
   Google Scholar
• TUOMILEHTO J, LINDSTROM J, ERIKSSON JG et al.: Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl. J. Med. (2001) 344:1343–1350.
   PubMed Web of Science ®Google Scholar
• MONTAGUE CT, FAROOQI IS, WHITEHEAD JP et al.: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 387:903–907.
   PubMed Web of Science ®Google Scholar
• FAROOQI IS, YEO GSH, KEOGH JM et al.: Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency." Clin. Invest. (2000) 106:271–279.
   Google Scholar
• VAISSE C, CLEMENT K, GUY-GRAND B, FROGUEL P: A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. (1998) 20:113–114.
   PubMed Web of Science ®Google Scholar
• VAISSE C, CLEMENT K, DURAND E et a/.: Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity." Clin. Invest. (2000) 106:253–262.
   Google Scholar